Houston, TX, United States of America

Seth Paul Lerner

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Baylor College of Medicine, Johns Hopkins University, Northwestern University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seth Paul Lerner. Retrieved from https://idiyas.com/inventor/seth-paul-lerner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seth Paul Lerner: Innovator in Bladder Cancer Research

Introduction

Seth Paul Lerner is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of cancer research, particularly in understanding bladder cancer. His innovative work has the potential to improve patient outcomes through advanced diagnostic methods.

Latest Patents

Seth Paul Lerner holds a patent titled "Methods for characterizing bladder cancer." This invention features methods for characterizing mutational profiles in patients with bladder cancer. His work in this area is crucial for developing targeted therapies and personalized medicine.

Career Highlights

Throughout his career, Lerner has worked with prestigious organizations, including the Broad Institute, Inc. and the General Hospital Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.

Collaborations

Lerner has collaborated with notable colleagues such as Jaegil Kim and Gad Getz. These partnerships have furthered his research and contributed to advancements in understanding bladder cancer.

Conclusion

Seth Paul Lerner is a dedicated inventor whose work in bladder cancer research exemplifies the importance of innovation in medicine. His contributions are paving the way for better diagnostic methods and treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…